Income before deduction of interest, taxes and amortization: omeros.com (OMER)
Omeros Corporation's team of elite immunologists and biochemists is building a foundation for growth, as confirmed by current operating profit in cash terms. The value of 0.00 represents the latest metric reading. The company's potential is based on the development of innovative complement inhibitors, while the current strategy focuses on restructuring the pipeline to secure approval for a key drug treating rare pathologies.
Omeros Corporation (OMER) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Omeros Corporation|OMER - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Omeros Corporation|OMER - Company Debts|Debts to Book Value Omeros Corp|OMER - Company Long-Term Debt|Company Short-Term Loans and Borrowings Omeros|Critical Liquidity Ratio omeros.com
- earnings and market multiples details:
OMER - Company Net Income|Expected Net Profit Omeros Corporation|OMER - Price to Earnings Ratio|Future Price to Earnings Multiple Omeros Corp.|OMER - PEG Multiple|EV/EBITDA Multiple Omeros Corp.|OMER - Operating profit before deduction of amortization|Earnings per share for the last four quarters Omeros|OMER - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months omeros.com|OMER - Earnings per share growth in current year|Expected net earnings per share growth next year Omeros Corporation
- sales and revenue data:
Analysis of all company metrics:Omeros Corporation
This indicator captures daily cash flow from core operations before taxes, interest, and depreciation, allowing for an assessment of the business's actual resilience to external shocks. By analyzing the operating result before depreciation on GURU.Markets, an investor can see the cost management efficiency, which Omeros Corporation (OMER) maintains through the diversification of raw material suppliers and the optimization of drug logistics.
Competitors of Omeros Corporation (OMER)
Biogen Inc. (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (Regencell Bioscience Holdings Limited) - Operating profit before amortization|Axsome Corp (AXSM) - Profit before payment of interest, taxes and amortization|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX - Operating profit before depreciation charges|Operating profit before deduction of amortization SUPN (supernus.com)|Operating income before deduction of amortization Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HRMY|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Operating profit EBITDA|Operating profit before amortization CBLL (CeriBell Corp)|Profit before payment of interest, taxes and amortization Prothena Biosciences (PRTA)|Operating income before deduction of amortization Alector|Operating profit EBITDA ANNX (annexonbio.com)|NGNE - Operating profit before deduction of amortization|ACIU - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VYGR|NMRA: Operating profit EBITDA|Scilex Holding Company - Income before deduction of interest, taxes and amortization|TVGN (Tevogen Bio Holdings, Inc.) - Operating profit EBITDA|Operating profit EBITDA Alpha Cognition|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Operating profit EBITDA SAVA (cassavasciences.com)|Income before deduction of interest, taxes and amortization ASRT|Coya Therapeutics Inc - Operating profit EBITDA|Operating income before deduction of amortization vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals, Inc (ABOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CervoMed Inc.|Alterity Therapeutics (ATHE) - Operating income before deduction of amortization|Operating profit EBITDA CLNN|PEPG - Profit before interest, taxes and amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences, Inc.)|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating profit before depreciation charges Grace Therapeutics (GRCE)|AIFF: Operating profit EBITDA|ANEW Medical, Inc. (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd.|RVPH: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MTVA|Operating profit EBITDA NeurAxis (NRXS)|Helius Medical Technologies, Inc. - Operating profit before deduction of amortization|Operating income before deduction of amortization Passage Bio, Inc. (PASG)|Neuphoria - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NERV (Minerva)|ATHA: Operating profit EBITDA|Operating profit before amortization ADXN|Operating profit before deduction of amortization ALZN|Profit before interest, taxes and amortization Cyclerion Therapeutics CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Operating profit EBITDA Pasithea Therapeutics Corp (KTTA)|Cortigent, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA Avenue Therapeutics ATXI|BCLI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CARA (Cara Therapeutics)|Chromocell Therapeutics Corporation (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|Profit before interest, taxes and amortization longboardpharma.com LBPH|Profit before payment of interest, taxes and amortization Marinus (MRNS)|Company profit before taxes, interest and amortization NKGN|Operating profit EBITDA NRBO (NeuroBo)|Income before deduction of interest, taxes and amortization SAGE|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena|VIGL: Operating profit EBITDA|WENA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Cerevel
